Cognition Therapeutics Inc
Research Cognition Therapeutics Inc (CGTX) on Bullrun: market cap USD 97.55M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCGTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 97.55M
- Financial periodFY2025
- Net income-USD 23.49M
Valuation Snapshot
latest market cap is USD 97.55M.
About Cognition Therapeutics Inc
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
Frequently asked questions
What is Cognition Therapeutics Inc's market cap?
Cognition Therapeutics Inc's market capitalization is USD 97.55M.
What does Cognition Therapeutics Inc do?
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.